CASP1 and cancer: Treating human-derived macrophages with the supernatants from co-cultured CD19-CAR-T cell and cancer cells (NALM-6, Raji, or primary B leukemic cells) prompted macrophage activation of caspase-1, cleavage of GSDMD, and release of IL-6 and IL-1β.